Drugs News and Research

RSS

UVA researchers discover genes responsible for the development of coronary artery disease

University of Virginia researchers and their collaborators have identified genes that play key roles in the development of coronary artery disease, the No. 1 cause of death worldwide.

2 Feb 2023

UC Davis launches new institute to advance basic knowledge of psychedelics and neurotherapeutics

The University of California, Davis has launched the Institute for Psychedelics and Neurotherapeutics to advance basic knowledge about the mechanisms of psychedelics and translate it into safe and effective treatments for diseases such as depression, post-traumatic stress disorder, addiction, Alzheimer's disease and Parkinson's disease, among others.

2 Feb 2023

What is the impact of anticancer therapy on patients with hematologic malignancies and COVID-19?

Researchers performed a systematic review and meta-analysis following the PRISMA guidelines.

2 Feb 2023

Characterization of Ikaros zinc finger protein 1 mutations in acute myeloid leukemia

Researchers evaluated the clinical and genetic characteristics of acute myeloid leukemia (AML) patients with a mutant Ikaros zinc finger protein 1 (IKZF1).

2 Feb 2023

Knowing your cholesterol level can be a crucial factor in overall health

On a top 10 list of things to do, getting your cholesterol level checked likely doesn't make the cut – but no matter your age, knowing your numbers can be a crucial factor in overall health.

2 Feb 2023

Immunomodulatory antibodies found to be successful in treating cancer when they have a looser grip

New research from the Centre for Cancer Immunology at the University of Southampton, published ahead of World Cancer Day (4 February), has shown that changing how tightly an antibody binds to a target could improve treatments for cancer.

1 Feb 2023

Mays Cancer Center leads a study evaluating Phase I and Phase III clinical trials for breast cancer drug

The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer.

1 Feb 2023

Light-activated nanoscale drills can combat infectious fungi

That stubborn athlete's foot infection an estimated 70% of people get at some point in their life could become much easier to get rid of thanks to nanoscale drills activated by visible light.

1 Feb 2023

A more nuanced approach is needed when prescribing antidepressants for pain, researchers say

Some antidepressant drugs are effective for some pain conditions, but most are either ineffective or the evidence is inconclusive, despite being used for a range of pain conditions, finds an overview of the latest evidence published by The BMJ today.

1 Feb 2023

New optogenetic tool to study and modulate plasticity in the cerebellum

Light can trigger a signaling cascade in the cerebellum. This also illuminates processes that play an important role in cerebellar diseases.

1 Feb 2023

CuSTOM; Creating a healthier society by accelerating the translation of organoid technology

In this interview, we speak to Magdalena Kasendra at the CuSTOM Accelerator, about the organoid technology and how it has the power the revolutionize healthcare.

From Society for Laboratory Automation and Screening (SLAS) 1 Feb 2023

Commonly prescribed antidepressants can increase bacteria's resistance to antibiotics

University of Queensland researchers have found a range of commonly prescribed antidepressants can increase bacteria's resistance to antibiotic medications.

1 Feb 2023

Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer

The "Pancreatic ductal adenocarcinoma" (PDAC) is by far the most common form of cancer of the pancreas. PDAC tumors have an extremely poor prognosis because of several reasons.

31 Jan 2023

Adding veliparib to chemotherapy can extend progression-free survival in patients with “BRCA-like” breast cancer

Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free survival (PFS) times in patients with triple-negative breast cancer (TNBC) that has a "BRCA-like" phenotype.

31 Jan 2023

Cancer immunotherapy does not interfere with COVID-19 immunity in vaccinated patients, study shows

Research findings published in Frontiers in Immunology show that cancer immunotherapy does not interfere with COVID-19 immunity in previously vaccinated patients.

31 Jan 2023

New nanomedicine delivery system offers some hope for treating peritoneal cancer

Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope.

31 Jan 2023

Setting new guidelines for innovative services to prevent Alzheimer's disease

Memory loss, behavioral changes, cognitive deficits: Alzheimer's disease leads to a dramatic loss of autonomy for those affected and has a heavy impact on health costs.

31 Jan 2023

Oral antibiotic eye infection tablet may be effective medicine for a treatment-resistant sex bug

An oral antibiotic tablet used to treat common eye infections may prove an effective medicine for a sexually transmitted bug that has become resistant to usual recommended treatment, suggest doctors in the journal Sexually Transmitted Infections.

31 Jan 2023

Sleep medications increase the risk of dementia in whites, study shows

A new study shows that sleep medications increase the risk of dementia in whites. But the type and quantity of the medication may be factors in explaining the higher risk.

31 Jan 2023

Acute tubulointerstitial nephritis and uveitis in children post-COVID-19

A new study reported a novel form of post-acute coronavirus disease 2019 (COVID-19) syndrome in children.

31 Jan 2023

Drugs News and Research

UVA researchers discover genes responsible for the development of coronary artery disease

UC Davis launches new institute to advance basic knowledge of psychedelics and neurotherapeutics

What is the impact of anticancer therapy on patients with hematologic malignancies and COVID-19?

Characterization of Ikaros zinc finger protein 1 mutations in acute myeloid leukemia

Knowing your cholesterol level can be a crucial factor in overall health

Immunomodulatory antibodies found to be successful in treating cancer when they have a looser grip

Mays Cancer Center leads a study evaluating Phase I and Phase III clinical trials for breast cancer drug

Light-activated nanoscale drills can combat infectious fungi

A more nuanced approach is needed when prescribing antidepressants for pain, researchers say

New optogenetic tool to study and modulate plasticity in the cerebellum

CuSTOM; Creating a healthier society by accelerating the translation of organoid technology

Commonly prescribed antidepressants can increase bacteria's resistance to antibiotics

Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer

Adding veliparib to chemotherapy can extend progression-free survival in patients with “BRCA-like” breast cancer

Cancer immunotherapy does not interfere with COVID-19 immunity in vaccinated patients, study shows

New nanomedicine delivery system offers some hope for treating peritoneal cancer

Setting new guidelines for innovative services to prevent Alzheimer's disease

Oral antibiotic eye infection tablet may be effective medicine for a treatment-resistant sex bug

Sleep medications increase the risk of dementia in whites, study shows

Acute tubulointerstitial nephritis and uveitis in children post-COVID-19

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News